Capecitabine Api - Pharmaceutical Active Ingredient, BP

Capecitabine API (CAS No. 154361‑50‑9) is a high‑purity nucleoside metabolic inhibitor Active Pharmaceutical Ingredient widely used in oral chemotherapy formulations for the treatment of various solid tumors. Capecitabine is a prodrug of 5‑fluorouracil (5‑FU) that undergoes enzymatic conversion in tumor tissues, allowing selective cytotoxic activity against rapidly dividing cancer cells while reducing systemic exposure. Once converted to 5‑FU, Capecitabine interferes with DNA synthesis and cell replication, leading to effective tumor growth inhibition. Capecitabine is commonly incorporated into regulated pharmaceutical formulations for the treatment of: Breast cancer Colorectal cancer Gastric (stomach) cancer Esophageal cancer Pancreatic cancer Other gastrointestinal malignancies It may be used as monotherapy or in combination regimens with other anticancer agents, depending on cancer type and stage. 🧪 Specifications & Details Product Name: Capecitabine Synonyms: Capecitabine Product Code: ATM172CAPE Grade: USP / EP / BP CAS Number: 154361‑50‑9 Molecular Formula: C15H22FN3O6 Molecular Weight: 359.35 g/mol COA & MSDS: Available on request 📦 Packaging & Storage Packaging: 25 Kg HDPE drums with double liner bags inside (export‑worthy) Storage Condition: Store in air‑tight containers Protect from direct light and moisture ⭐ Key Features Manufactured in WHO‑GMP compliant facilities High‑purity anticancer API with controlled impurity profile Tumor‑targeted prodrug for improved tolerability Suitable for oral solid dosage forms (tablets) Widely accepted in global oncology treatment protocols Consistent batch‑to‑batch quality Export‑grade material with complete documentation (COA, MSDS) 💊 Applications Used in regulated pharmaceutical formulations for: Oral chemotherapy tablets Breast & colorectal cancer treatment products Gastrointestinal oncology therapies Combination chemotherapy regimens Long‑term cancer management protocols Capecitabine API, Anticancer Bulk Drug, Oral Chemotherapy API, 5‑FU Prodrug Ingredient, Colorectal Cancer Treatment Raw Material, Oncology Pharmaceutical API, Active Pharmaceutical Ingredient, CAS 154361‑50‑9, USP Grade, EP Grade, BP Grade, WHO‑GMP Certified, Pharmaceutical Export. #Capecitabine #PharmaceuticalAPI #AnticancerAPI #OralChemotherapy #Oncology #CancerTreatment #BulkDrugs #ActiveIngredient #PharmaExport #CAS154361509 #USPGrade #EPGrade #BPGrade About the Company GST Registration Date: 2020 Legal Status of Firm: Proprietorship Number of Employees: 11 To 25 People Annual Turnover: 40 L - 1.5 Cr